GSK Cash Flow Statement | Ticker | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | YoY | Trend |
|---|
| Operating Activities |
| Profit Before Tax | £7.4B | £3.5B | £6.1B | £5.6B | £5.4B | £7.0B | +112.9% | |
| Net Cash from Operating | £7.7B | £6.6B | £6.8B | £7.4B | £8.0B | £8.4B | +18.1% | |
| Investing Activities |
| Capital Expenditure | £1.3B | £1.4B | £1.3B | £1.1B | £1.2B | £1.2B | -3.6% | |
| Acquisitions | £1.7B | £805.0M | — | — | — | — | +110.2% | |
| Net Cash from Investing | -£4.2B | -£1.2B | -£1.6B | -£8.8B | -£1.8B | £2.2B | -244.4% | |
| Financing Activities |
| Share Issues | £15.0M | £20.0M | £10.0M | £25.0M | £21.0M | £29.0M | -25.0% | |
| Share Buybacks | £1.4B | — | — | — | — | — | — | |
| Dividends Paid | £2.6B | £2.4B | £2.2B | £3.5B | £4.0B | £4.0B | +4.9% | |
| Net Cash from Financing | -£3.7B | -£4.7B | -£5.6B | £823.0M | -£7.6B | -£10.1B | +22.0% | |
| Cash Movement |
| FX Adjustments | -£19.0M | -£54.0M | -£99.0M | £152.0M | -£29.0M | -£39.0M | +64.8% | |
Currency: GBPPeriods: 6
Source: Annual Reports | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | YoY | Trend |
|---|
| Operating Activities |
| Profit Before Tax | £7.4B | £3.5B | £6.1B | £5.6B | £5.4B | £7.0B | +112.9% | |
| Net Cash from Operating | £7.7B | £6.6B | £6.8B | £7.4B | £8.0B | £8.4B | +18.1% | |
| Investing Activities |
| Capital Expenditure | £1.3B | £1.4B | £1.3B | £1.1B | £1.2B | £1.2B | -3.6% | |
| Acquisitions | £1.7B | £805.0M | — | — | — | — | +110.2% | |
| Net Cash from Investing | -£4.2B | -£1.2B | -£1.6B | -£8.8B | -£1.8B | £2.2B | -244.4% | |
| Financing Activities |
| Share Issues | £15.0M | £20.0M | £10.0M | £25.0M | £21.0M | £29.0M | -25.0% | |
| Share Buybacks | £1.4B | — | — | — | — | — | — | |
| Dividends Paid | £2.6B | £2.4B | £2.2B | £3.5B | £4.0B | £4.0B | +4.9% | |
| Net Cash from Financing | -£3.7B | -£4.7B | -£5.6B | £823.0M | -£7.6B | -£10.1B | +22.0% | |
| Cash Movement |
| FX Adjustments | -£19.0M | -£54.0M | -£99.0M | £152.0M | -£29.0M | -£39.0M | +64.8% | |
Currency: GBPPeriods: 6
Source: Annual Reports
